PT  - JOURNAL ARTICLE
AU  - Rentsch, Christopher T.
AU  - Kidwai-Khan, Farah
AU  - Tate, Janet P.
AU  - Park, Lesley S.
AU  - King, Joseph T.
AU  - Skanderson, Melissa
AU  - Hauser, Ronald G.
AU  - Schultze, Anna
AU  - Jarvis, Christopher I.
AU  - Holodniy, Mark
AU  - Lo Re, Vincent
AU  - Akgün, Kathleen M.
AU  - Crothers, Kristina
AU  - Taddei, Tamar H.
AU  - Freiberg, Matthew S.
AU  - Justice, Amy C.
TI  - Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans
AID  - 10.1101/2020.05.12.20099135
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.12.20099135
4099  - http://medrxiv.org/content/early/2020/05/18/2020.05.12.20099135.short
4100  - http://medrxiv.org/content/early/2020/05/18/2020.05.12.20099135.full
AB  - Background There is growing concern that racial and ethnic minority communities around the world are experiencing a disproportionate burden of morbidity and mortality from symptomatic SARS-Cov-2 infection or coronavirus disease 2019 (Covid-19). Most studies investigating racial and ethnic disparities to date have focused on hospitalized patients or have not characterized who received testing or those who tested positive for Covid-19.Objective To compare patterns of testing and test results for coronavirus 2019 (Covid-19) and subsequent mortality by race and ethnicity in the largest integrated healthcare system in the United States.Design Retrospective cohort study.Setting United States Department of Veterans Affairs (VA).Participants 5,834,543 individuals in care, among whom 62,098 were tested and 5,630 tested positive for Covid-19 between February 8 and May 4, 2020.Exposures Self-reported race/ethnicity.Main outcome measures We evaluated associations between race/ethnicity and receipt of Covid-19 testing, a positive test result, and 30-day mortality, accounting for a wide range of demographic and clinical risk factors including comorbid conditions, site of care, and urban versus rural residence.Results Among all individuals in care, 74% were non-Hispanic white (white), 19% non-Hispanic black (black), and 7% Hispanic. Compared with white individuals, black and Hispanic individuals were more likely to be tested for Covid-19 (tests per 1000: white=9.0, [95% CI 8.9 to 9.1]; black=16.4, [16.2 to 16.7]; and Hispanic=12.2, [11.9 to 12.5]). While individuals from minority backgrounds were more likely to test positive (black vs white: OR 1.96, 95% CI 1.81 to 2.12; Hispanic vs white: OR 1.73, 95% CI 1.53 to 1.96), 30-day mortality did not differ by race/ethnicity (black vs white: OR 0.93, 95% CI 0.64 to 1.33; Hispanic vs white: OR 1.07, 95% CI 0.61 to 1.87).Conclusions Black and Hispanic individuals are experiencing an excess burden of Covid-19 not entirely explained by underlying medical conditions or where they live or receive care. While there was no observed difference in mortality by race or ethnicity, our findings may underestimate risk in the broader US population as health disparities tend to be reduced in VA.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by National Institute on Alcohol Abuse and Alcoholism [U01-AA026224, U24-AA020794, U01-AA020790, U10-AA013566]. The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe analytic data sets used are not permitted to leave the VA firewall. This limitation is consistent with the authors' past work and with other studies based on VA data.